You can make a choice when it comes to your COVID‑19 vaccine

Want to learn about the Novavax COVID‑19 Vaccine, Adjuvanted
(2023-2024 Formula)?

Select a topic below to see commonly asked questions and answers.

The Novavax COVID‑19 Vaccine, Adjuvanted is a protein-based vaccine that's available for people 12 years of age and older to prevent COVID‑19. The FDA has authorized the use of this vaccine under an Emergency Use Authorization (EUA).

The Novavax COVID‑19 Vaccine, Adjuvanted is a protein-based vaccine. It uses technology similar to what’s used in some vaccines for hepatitis B and the flu.

Protein-based vaccines use small pieces of a virus protein. This protein cannot cause the disease. Our bodies learn to recognize the protein as a foreign invader so that when we are exposed to the actual virus, our immune systems can attack it more efficiently.

Protein-based vaccines have been used before to help protect against diseases such as hepatitis B and the flu. This type of vaccine is often combined with an ingredient called an adjuvant, which may help enhance your body's immune response.

An adjuvant is an added ingredient in some vaccines that may help enhance the immune system’s response to the vaccine.

No. The Novavax COVID‑19 Vaccine, Adjuvanted uses traditional, protein-based technology and is a non-mRNA option.

During a public health emergency, such as the COVID‑19 pandemic, the US Food and Drug Administration (FDA) may allow the use of unapproved medical products, including vaccines, or unapproved uses of approved medical products to diagnose, treat, or prevent serious or life-threatening diseases or conditions.

Before issuing an EUA, the FDA will evaluate and determine if all lawful criteria are met, including reviewing all scientific evidence about the vaccine that is available to it. Learn more about the FDA’s EUA approval process here.

Novavax is a biotech company that focuses only on vaccines. They use innovative technology to help protect people around the globe from emerging infectious diseases.

Side effects that have been reported in clinical trials with the Novavax COVID‑19 Vaccine, Adjuvanted include myocarditis (inflammation of the heart muscle), pericarditis (inflammation of the lining outside the heart), injection site reactions (pain/tenderness, swelling, redness, and itching), fatigue or generally feeling unwell, muscle pain, headache, joint pain, nausea, vomiting, fever, chills, allergic reactions such as hives and swelling of the face, and swollen lymph nodes. These may not be all the possible side effects. Serious and unexpected side effects may occur. The possible side effects are still being studied.

Getting this vaccine

Yes. If you are 12 years of age or older, you can get the Novavax COVID‑19 Vaccine, Adjuvanted at least 2 months after your last dose of any COVID‑19 vaccine.*

*"Any COVID‑19 vaccine" refers to a monovalent or bivalent COVID‑19 vaccine.

Yes. According to the Centers for Disease Control and Prevention (CDC), flu vaccines and COVID‑19 vaccines like the Novavax COVID‑19 Vaccine, Adjuvanted can be given at the same visit if you are due for both vaccines.

Yes. The Novavax COVID‑19 Vaccine, Adjuvanted was studied in people 65 years of age and older. The Novavax COVID‑19 Vaccine, Adjuvanted is given to people 12 years of age and older.

It is recommended by the CDC that people 65 and older receive an additional dose of a 2023-2024 formula COVID-19 vaccine at least 4 months after their last 2023-2024 COVID-19 vaccine dose.

Yes. You can get the Novavax COVID‑19 Vaccine, Adjuvanted if you are 12 years of age or older and have not previously been vaccinated with any COVID‑19 vaccine.* Two doses will be given 3 weeks apart.

*"Any COVID‑19 vaccine" refers to a monovalent or bivalent COVID‑19 vaccine.

Yes. If you're 12 years of age or older, you can get the Novavax COVID‑19 Vaccine, Adjuvanted at least 2 months after your last dose of any COVID‑19 vaccine.* Getting an updated vaccine can help strengthen your protection against COVID‑19, as the effects of your previous vaccine may decrease over time.

*"Any COVID‑19 vaccine" refers to a monovalent or bivalent COVID‑19 vaccine.

No. Children under the age of 5 cannot get the Novavax COVID‑19 Vaccine, Adjuvanted. Safety and effectiveness in children younger than 12 years of age have not been established.

No. The Novavax COVID‑19 Vaccine, Adjuvanted is authorized to prevent COVID‑19 in people 12 years of age and older. Safety and effectiveness in children younger than 12 years of age have not been established.

If you are pregnant or breastfeeding, be sure to discuss your options with your healthcare provider.

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to the Novavax COVID‑19 Vaccine, Adjuvanted during pregnancy. Women who are vaccinated with the Novavax COVID‑19 Vaccine, Adjuvanted during pregnancy are encouraged to enroll in the registry by visiting
https://c-viper.pregistry.com.

You should not get the Novavax COVID‑19 Vaccine, Adjuvanted if you had a severe allergic reaction after a previous dose of any Novavax COVID‑19 Vaccine, Adjuvanted or if you had a severe allergic reaction to any ingredient of these vaccines.

About this vaccine

The Novavax COVID‑19 Vaccine, Adjuvanted includes:

  • A version of the SARS-CoV-2 spike protein that was created in a lab
  • The Matrix-M™ adjuvant, which contains an ingredient that comes from the bark of a Chilean tree. An adjuvant is an added ingredient that may help enhance your body’s immune response

Other ingredients include cholesterol, phosphatidylcholine, potassium dihydrogen phosphate, potassium chloride, disodium hydrogen phosphate dihydrate, sodium chloride, disodium hydrogen phosphate heptahydrate, sodium dihydrogen phosphate monohydrate, and polysorbate 80. The vaccine may also contain small amounts of baculovirus and insect cell proteins and DNA. The vaccine does not contain mRNA.

No. The vaccine does not contain preservatives and the vial stoppers are not made with natural rubber latex.

The Novavax COVID‑19 Vaccine, Adjuvanted contains a version of the SARS-CoV-2 spike protein that has been produced in a lab.

The spike protein helps create an immune response in your body. This helps protect you from getting sick with COVID‑19 if you come across it in the future.

The Novavax COVID‑19 Vaccine, Adjuvanted is given to people 12 years of age or older as an injection into the muscle.

  • Single dose: If you are 12 or older and you've been vaccinated before with any COVID‑19 vaccine,* a single dose of the Novavax COVID‑19 Vaccine, Adjuvanted is given at least 2 months after your last dose of a COVID‑19 vaccine
  • 2-dose series: If you are 12 or older and you have not been vaccinated before with any COVID‑19 vaccine,* 2 doses of the Novavax COVID‑19 Vaccine, Adjuvanted are given. The second dose will be given 3 weeks after the first dose

*"Any COVID‑19 vaccine" refers to a monovalent or bivalent COVID‑19 vaccine.

No. The Novavax COVID‑19 Vaccine, Adjuvanted does not contain the virus that causes COVID‑19.

There is a remote chance that the Novavax COVID‑19 Vaccine, Adjuvanted could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Novavax COVID‑19 Vaccine, Adjuvanted. For this reason, your vaccination provider may ask you or your child to stay at the place where you or your child received the vaccine for monitoring after vaccination.

Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received the vaccine. In most of these people, symptoms began within 10 days following vaccination. The chance of having this occur is very low.